Mija, L. A., and A. Elkrief. “Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-Small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?”. Canadian Oncology Today, vol. 2, no. 1, Apr. 2025, pp. 13–17, doi:10.58931/cot.2025.2131.